Lewis, Eldrin F.
Coles, Theresa M.
Lewis, Sandy
Nelson, Lauren M.
Barrett, Amy
Romano, Carla DeMuro
Stull, Donald E.
Turner, Stuart J.
Chang, Chunlan G.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 24 August 2018
Accepted: 28 March 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: All study procedures were approved by the Office of Research Protection and Ethics at RTI International (FWA #3331). All patient and caregiver participants provided informed consent. Clinician interviews were considered exempt from research because clinicians were providing information based on their clinical expertise as opposed to information about themselves or specific patients.
: Not applicable.
: The study was conducted by RTI Health Solutions, Research Triangle Park, NC, USA, which received consultancy fees from Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. RTI Health Solutions conducted the data collection and analysis. T. M. Coles, <i>S. Lewis</i>, L. M. Nelson, A Barrett, C. Romano, and D. E. Stull of RTI Health Solutions; S. J. Turner and C.-L. Chang of Novartis; and E. Lewis of Brigham and Women’s Hospital, Boston, MA USA, collaborated on the study design, interpretation of data, and decision to submit these data for publication.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.